(Q38132100)

29 August 2017

title

Analytical and clinical evaluation of biomarkers assays: when are biomarkers ready for prime time? (English)

1 reference

29 August 2017

0 references

Gene A Pennello

1

1 reference

29 August 2017

publication date

27 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

10

1 reference

29 August 2017

issue

5

1 reference

29 August 2017

page(s)

666-676

1 reference

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Next-generation sequencing: from basic research to diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Assessing the clinical utility of diagnostics used in drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Biases in the assessment of diagnostic tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Missing data in the regulation of medical devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Bayesian analysis of diagnostic test accuracy when disease state is unverified for some subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Reporting recommendations for tumor marker prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Strengthening the reporting of genetic risk prediction studies: the GRIPS statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Maximum Likelihood Approaches to Variance Component Estimation and to Related Problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Random-effects models for longitudinal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

The efficacy of diagnostic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Evidence based diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Phases of biomarker development for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

The architecture of diagnostic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Assessing the performance of prediction models: a framework for traditional and novel measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Measuring the performance of markers for guiding treatment decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

FDA holds court on post hoc data linking KRAS status to drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

Use of archived specimens in evaluation of prognostic and predictive biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

What should physicians look for in evaluating prognostic gene-expression signatures?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774513497541

21 January 2018

Identifiers

DOI

10.1177/1740774513497541

1 reference

29 August 2017

1 reference